Resumen

MARTINEZ-CASTRO, Raúl et al. Thrombotic events. Gac. Méd. Méx [online]. 2022, vol.158, suppl.3, pp.47-56.  Epub 26-Ago-2025. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m22000668.

Major thrombotic complications in myeloproliferative neoplasms (MPN) represent an important clinical problem due to their high morbidity, the complexity of their management and their associated mortality. The appearance of a thrombosis implies a high thrombotic risk stratification of the MPN and determines the initiation or optimization of cytoreductive treatment and the use of antiplatelet or anticoagulant therapy as secondary prophylaxis. The incidence of thrombosis at the time of diagnosis is higher than during the course of the disease, being located in the arterial territory in 60-70% of cases. Once thrombosis has occurred, up to 20-33% of patients experience thrombotic recurrence in the same initial vascular territory.

Palabras llave : Thrombosis; Myeloproliferative neoplasia; Anticoagulation; Prophylaxis.

        · resumen en Español     · texto en Español     · Español ( pdf )